Personalized drug screening on horizon for multiple ​myeloma patients​​​​

​A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process, developed by scientists at Washington University School of Medicine​ in St. Louis, also may aid patients with leukemia or lymphoma.

Silverman named head of pediatrics​

Gary A. Silverman, MD, PhD, has been named the Harriet B. Spoehrer Professor and head of the Department of Pediatrics at Washington University School of Medicine in St. Louis. With the new appointment, effective in April, Silverman will become pediatrician-in-chief at St. Louis Children’s Hospital and executive director of the Children’s Discovery Institute, a partnership of the school and hospital.
Washington University receives $1.6 million Gates Foundation grant

Washington University receives $1.6 million Gates Foundation grant

Washington University in St. Louis has received a two-year, $1.6 million grant from the Bill & Melinda Gates Foundation. Wolfgang Munar, MD, associate director for Global Social Policy at the Brown School’s Social System Design Lab and associate director of the Institute for Public Health’s Global Health Center, is the project’s primary investigator. The grant money will be used to test a novel methodology that will measure the social structures that enhance or limit adoption of modern contraceptives in rural Ethiopia.
Flipping the switch to better see cancer cells at depths

Flipping the switch to better see cancer cells at depths

​A team of engineers, led by Washington University’s Lihong Wang and postdoctoral researcher Junjie Yao, found that by genetically modifying glioblastoma cancer cells to express BphP1 protein, derived from a bacterium commonly found in soil and water, they could clearly see tiny amounts of live cancer cells as deep as 1 centimeter in tissue using photoacoustic tomography.
Older Stories